2012年更新

受賞

●日本白血病研究基金　一般研究賞(2005)

応用分野

●造血細胞移植の臨床に直接的に応用可能なものである。

所属学会

●日本小児科学会　　　　　　　　　　　　　　　　　　　　　●日本血液学会
●日本小児血液がん学会　　　　　　　　　　　　　　　　　　●日本造血細胞移植学会
●American Society for Blood and Marrow Transplantation

論文

●Hirayama M et al. Interleukin-10 spot-forming cells as a novel biomarker of chronic graft-versus-host disease. Haematologica　(in press)
●Hirayama M et al. Tolerogenic effect of non-inherited maternal antigens in hematopoietic stem cell transplantation. Frontiers in immunology 3(5):135, 2012
●Hosoki K, Hirayama M, et al. Elevated numbers of cells producing interleukin-5 and interleukin-10 in a boy with kimura disease. Int Arch Allergy and Immunol 158 (suppl 1):70-74, 2012
●Hirayama M et al. Increased level of IFN-γ and IL-4 spot-forming cells on ELISPOT assay as biomarker for acute graft-versus-host disease and concurrent infections. Cells 1(2):61-73,2012
●Iwamoto S, Kumamoto T, Azuma E, Hirayama M, et al. The effect of azithromycin on the maturation and function of murine bone marrow-derived dendritic cells. Clin Exp Immunol 166: 385-92, 2011
●Hirayama M, Azuma E. Major and minor histocompatibility antigens to NIMA: Prediction of a tolerogenic NIMA effect. Chimerism 2: 23-24, 2011
●Araki M, Hirayama M,et al. Prediction of reactivity to non-inherited maternal antigen in MHC-mismatched, minor histocompatibility antigen-matched stem cell transplantation in a mouse model. J Immunol 185: 7739-45, 2010
●Tomizawa D, Koh K, Hirayama M,et al. Outcome of recurrent or refractory acute lymphoblastic leukemia in infants with MLL gene rearrangements: A report from the Japan Infant Leukemia Study Group. Pediatr Blood Cancer 52: 808-13, 2009
●Miyahara M, Hirayama M, et al. Too young to talk of vertigo? Lancet 373: 516, 2009

著書

●Hirayama M, Azuma E, Komada Y. Major and minor histocompatibility antigens to non-inherited maternal antigens (NIMA). Histocompatibility, Chapter 9: 145-162, May, 2012. ISBN 978-953-51-0589-3

論文等

●Hirayama M, Azuma E, Komada Y. A biomarker for discrimination of acute graft-versus-host disease from systemic infections: Response to paper by Levine JE et al. in 2012. [e-Letter], Blood June 7, 2012.
●Hirayama M, Azuma E, Komada Y. Successful treatment by donor lymphocyte infusion for severe norovirus infection after allogeneic bone marrow transplantation: Response to paper by Schwartz S et al. in 2011. [e-Letter], Blood, July 27, 2011

関連ホームページ

• 三重大学小児科